Indium-111
In-111 · Indium, Z = 49, A = 111
Indium-111 (In-111) carries 1.55e+16 Bq/g, or 4.20e+5 Ci/g: a gigabecquerel is 64.4 ng, no weighable quantity at all. It decays by electron capture with a half-life of 2.8047 days, which leaves 17.73% of today's activity after a week and 1.7e-8% after three months.
An air kerma rate constant of 0.0766 mGy·m²/(GBq·h) is about the same as Cs-137 and 4.0× less than Co-60, and 28 of 96 among the photon emitters carried here.
A half-value layer of 0.208 mm in lead puts this in foil and thin sheet, with 1.94 mm needed if the material is steel; ten-fold attenuation comes at 2.00 mm of lead. Reaching 20 µSv/h from 1 GBq at a metre takes 0.874 mm of lead. The tenth-value layer runs 9.6 times the half-value layer, not the 3.32 a single energy would give.
In-111 for labelled white cells and receptor imaging
In-111 labels white blood cells and platelets for imaging infection and thrombosis, and bound to the peptide pentetreotide it images tumours that carry somatostatin receptors. Its decay by electron capture leaves no beta, but it emits two gamma lines of convenient energy for a gamma camera and many Auger electrons absorbed close to the decay site, which has made it a candidate for therapy when carried into a cell nucleus.
Cadmium X-rays share the dose rate with those two lines, and because thin lead absorbs the X-rays first, the tenth-value layer is many half-value layers thick. Cameras use a medium-energy collimator for it, often with two energy windows together. The two gamma photons are emitted in cascade through one cadmium level, so a well counter or nearby germanium detector can record both as one event, taking counts from both full-energy peaks and adding a sum peak at their combined energy; calibrations based on single-line standards need a summing correction. In an activity calibrator the container wall absorbs part of the cadmium X-rays, so a syringe and the supplier's vial can read differently.
The half-life of days suits cell-labelling studies, which image a day or two after injection, and the waste is held for a month. Activity from labelled cells settles in the spleen, liver and marrow, and little is excreted; the spleen receives the highest organ dose. Cyclotrons make it by proton irradiation of cadmium, and it is supplied as indium chloride in dilute hydrochloric acid or as the oxine complex for cell labelling. Cadmium targets leave variable traces of In-114m, whose half-life runs to weeks; an alpha-on-silver route avoids it but yields far less. Because In-114m decays so much more slowly than In-111, a month of holding leaves most of it, and a survey before disposal shows what remains.
Oxine carries the indium into white cells as a neutral, lipid-soluble complex, and the metal then binds to cytoplasmic proteins. Plasma transferrin degrades that complex, so cells are labelled in saline once the plasma has been removed. Labelled cells are reinjected and cannot be sterilised, so the work is aseptic, in a laminar-flow cabinet or isolator, and different patients' cells are kept apart. Technetium-labelled cells have largely replaced indium ones, though indium cells are still preferred in the abdomen, where the technetium agent is excreted into the bowel.
- LNHB / DDEP, Recommended nuclear data tables: In-111
- IAEA Technical Reports Series No. 468, Cyclotron Produced Radionuclides: Physical Characteristics and Production Methods
- IAEA Technical Reports Series No. 454, Quality Assurance for Radioactivity Measurement in Nuclear Medicine
- EANM, Guidelines for the labelling of leucocytes with 111In-oxine (Eur J Nucl Med Mol Imaging)
Half-life, specific activity and dose rate
| Half-life | 2.8047 days (2.423e+5 s) |
| Decay mode | electron capture |
| Specific activity | 1.55e+16 Bq/g (4.20e+5 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.0766 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.0766 mGy/h |
| Dose rate, 1 Ci at 1 m | 2.84 mGy/h |
| Kerma-weighted mean photon energy | 143.9 keV |
7 lines above the cutoff, and what each contributes
One further line below the 20 keV cutoff, at 3.39 keV with 6.76% emission probability, is excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 245.35 | 94.09 | 38.32 |
| 171.28 | 90.65 | 23.95 |
| 23.17 | 44.32507 | 21.02 |
| 22.98 | 23.56764 | 11.37 |
| 26.18 | 12.35509 | 4.54 |
| 26.64 | 2.24863 | 0.80 |
| 150.81 | 0.003 | 0.00 |
0.208 mm of lead halves this spectrum
Solved numerically across all 7 lines, narrow beam. Why not one representative energy.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 0.208 | 2.00 | 9.63 |
| tungsten | 0.155 | 1.48 | 9.59 |
| iron | 1.94 | 16.5 | 8.48 |
| copper | 1.60 | 13.7 | 8.54 |
| concrete | 8.44 | 63.7 | 7.55 |
| water | 28.0 | 137 | 4.91 |
| aluminum | 7.18 | 56.9 | 7.93 |
A single energy would give 3.32. Spectrum and attenuation ratios.
Activity over days and weeks
Ten half-lives is 28.0 days — for In-111 itself, a storage problem rather than a disposal one, since those ten half-lives already take it below 0.1% of today's activity. The mean life 1/λ is 4.05 days.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.13 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 9.32 days |
| Time to fall to 1 % | 18.6 days |
| Time to fall to 0.1 % | 28.0 days |
Limits of these dose rates
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma and decay calculators for In-111
Other Indium nuclides: In-111m
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.